Author:
Edition: 2012
Publisher: Springer
Binding: Kindle Edition
ISBN: B007EMIT46
Retinal Degenerative Diseases: 723 (Advances in Experimental Medicine and Biology)
This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. Medical books Retinal Degenerative Diseases. Medical books New Insights Into Retinal Degenerative Diseases. Categories: Retinal Degeneration->physiopathology->congresses, Retinal Degeneration->genetics->congresses, Retinal degeneration->Congresses. Contributors: Robert E. Anderson - Author. Format: Hardcover
Download link for Retinal Degenerative Diseases: Laboratory and Therapeutic Investigations
Categories: Retinal Degeneration->physiopathology->congresses, Retinal Degeneration->genetics->congresses, Retinal degeneration->Congresses. Contributors: Robert E. Anderson - Author. Format: Hardcover
Categories: Retinal Degeneration->physiopathology->congresses, Retinal Degeneration->genetics->congresses, Retinal degeneration->Congresses. Contributors: Robert E. Anderson - Author. Format: Hardcover
Categories: Retinal Degeneration->physiopathology->congresses, Retinal Degeneration->genetics->congresses, Retinal degeneration->Congresses. Contributors: Robert E. Anderson - Author. Format: Hardcover
Store Search search Title, ISBN and Author New Insights Into Retinal Degenerative Diseases by Robert E. Anderson, Matthew M. Lavail Estimated delivery 3-12 business days Format Hardcover Condition Brand New This book contains the proceedings of the IX International Symposium on Retinal Degeneration held October 9-14, 2000, in Durango, Colorado. A majority of those who spoke and presented posters at the meeting contributed to this volume. The chapters reflect a major emphasis on molecular geneti
Medical Book Retinal Degenerative Diseases
The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
